e
abstractmycoplasma
pneumonia
one
common
known
bacteri
pathogen
respiratori
tract
especi
patient
year
age
may
encount
rel
high
rate
nonlifethreaten
fraction
emerg
depart
ed
patient
present
upper
respiratori
symptom
cough
yet
hallmark
nonspecif
includ
great
varieti
present
mild
pharyng
potenti
lifethreaten
complic
stevensjohnson
syndrom
describ
typic
case
pneumonia
due
mycoplasma
pneumonia
young
adult
mild
pharyng
lead
symptom
diseas
present
complic
diagnost
mean
therapeut
option
suspici
clinic
set
discuss
provid
review
clinic
aspect
diseas
import
ed
set
elsevi
inc
e
keywordsatyp
pneumonia
upper
airway
infect
pharyng
mycoplasma
pneumonia
clinic
commun
adult
coordin
ron
wall
md
mycoplasma
smallest
known
freeliv
organ
unlik
bacteria
lack
rigid
cell
wall
structur
therefor
suscept
antibiot
interfer
cell
wall
synthesi
betalactam
mycoplasma
speci
found
human
act
commens
mucos
surfac
howev
mycoplasma
pneumonia
common
caus
acut
respiratori
tract
infect
particularli
children
young
adult
relat
syndrom
atyp
pneumonia
human
pathogen
speci
includ
genitalium
ureaplasma
urealyticum
homini
caus
urogenit
infect
pneumonia
produc
influenzalik
respiratori
ill
gradual
onset
headach
malais
fever
cough
especi
common
young
peopl
despit
ubiqu
ambulatori
set
pneumonia
may
one
least
frequent
diagnos
respiratori
pathogen
emerg
depart
ed
primarili
clinic
hallmark
nonspecif
includ
great
varieti
present
mild
pharyng
potenti
lifethreaten
complic
stevensjohnson
syndrom
despit
difficulti
correct
diagnosi
remain
crucial
appropri
antibiot
treatment
pneumonia
infect
diagnos
certainti
situat
pneumonia
infect
like
recogn
physician
allow
empir
treatment
provid
review
clinic
aspect
pneumonia
infect
togeth
case
report
diseas
present
complic
diagnost
mean
therapeut
option
suspici
clinic
set
discuss
respect
need
emerg
physician
previous
healthi
woman
present
ed
sore
throat
complain
mild
cough
produc
whitish
mucu
hoars
headach
musculoskelet
pain
previou
day
vital
sign
normal
blood
pressur
mm
hg
heart
rate
beatsmin
respiratori
rate
breathsmin
oral
temperatur
examin
exsud
posterior
pharyng
wall
auscult
lung
normal
laboratori
find
follow
wbc
esr
normal
creactiv
protein
moder
elev
mgdl
refer
rang
mgdl
capillari
blood
ga
analysi
breath
ambient
air
po
mm
hg
pco
mm
hg
ph
sat
surprisingli
environment
histori
reveal
spous
mycoplasma
pneumoniaeinduc
pneumonia
complic
stevensjohnson
syndrom
week
prior
patient
symptom
mild
compat
specif
pneumonia
infect
yet
consid
diagnosi
follow
reason
clear
histori
exposur
cough
produc
sputum
musculoskelet
pain
chest
xray
studi
perform
show
infiltr
right
upper
lobe
figur
diagnosi
pneumonia
like
secondari
pneumonia
establish
empir
antibiot
treatment
mycoplasma
initi
accord
current
recommend
use
macrolid
case
erythromycin
mg
po
qid
day
throat
swab
sputum
cultur
perform
patient
discharg
ed
ambulatori
followup
week
patient
symptomfre
infect
mycoplasma
could
confirm
increas
antimycoplasma
iggtit
uml
present
uml
day
wherea
igm
normal
time
control
pulmonari
chest
xray
studi
shown
day
present
normal
present
case
pharyng
cough
lead
symptom
pneumoniaeassoci
pneumonia
gener
pharyng
may
caus
extens
varieti
agent
viral
bacteri
origin
tabl
infect
pneumonia
run
low
list
pharyng
selflimit
requir
treatment
howev
pharyng
cough
common
respiratori
tract
symptom
respect
mycoplasma
upperairwayinfect
turn
may
progress
pneumonia
tracheobronch
case
symptom
occur
type
pneumonia
infect
includ
fever
malais
headach
myalgia
rhinorrhea
ear
discomfort
chest
discomfort
communityacquir
pneumonia
pneumonia
identifi
etiolog
agent
roughli
case
depend
popul
studi
tabl
subject
cyclic
variat
peak
everi
year
gener
believ
account
pneumonia
importantli
least
five
studi
pneumonia
ambulatori
patient
pneumonia
lead
pathogen
case
highlight
import
pathogen
emerg
physician
highest
incid
pneumonia
infect
pulmonari
involv
found
age
group
year
incub
period
week
multipl
member
famili
affect
often
present
serial
week
interv
initi
physic
examin
pulmonari
auscult
often
normal
henc
abnorm
find
lung
examin
limit
sensit
detect
pneumon
seen
radiograph
later
diseas
patient
radiolog
pneumon
develop
scatter
rale
wheez
chest
xray
studi
show
either
bronchopneumonialik
pattern
disclik
atelectasi
nodular
infiltr
hilar
adenopathi
mani
patient
pneumonia
infect
may
experi
extrapulmonari
complic
nervou
system
involv
infect
patient
enceph
cerebellar
ataxia
transvers
myeliti
syndrom
peripher
neuropathi
cardiac
involv
patient
myocard
pericard
respiratori
distress
syndrom
lung
abscess
hemolyt
anemia
coagulopathi
musculoskelet
symptom
isol
mucos
dissemin
infect
immunocompromis
host
skin
rash
differ
sever
complic
secondari
autoimmun
suggest
respons
sever
form
skin
complic
stevensjohnson
syndrom
sj
occur
case
mycoplasma
pneumonia
preferenti
affect
young
male
character
gener
exanthema
high
fever
mucos
catarrh
symptom
pediatr
patient
sj
almost
exclus
caus
pneumonia
infect
wherea
similar
skin
rash
erythema
multiform
less
sever
differ
bodydistribut
histolog
mainli
due
herp
simplex
infect
adult
popul
sj
mostli
druginduc
drug
implic
mechan
includ
antimicrobi
sulfonamid
aminopenicillin
cephalosporin
quinolon
nsaid
oxicam
allopurinol
steroid
carbamazepin
phenobarbit
phenytoin
musclerelax
chlormezanon
withdrawn
mani
market
immedi
discontinu
offend
drug
shown
reduc
fatal
outcom
henc
sj
occur
treatment
pneu
monia
antimicrobi
class
switch
immedi
diagnosi
pneumonia
pneumonia
secur
clinic
mean
alon
requir
laboratori
confirm
avail
method
detect
cold
agglutinin
iga
igm
igg
direct
antigen
detect
eg
antigencaptur
enzymelinkedimmunoassay
eia
antigenamplif
polymerasechainreactionpcr
cultur
unfortun
method
gener
allow
reliabl
rapid
diagnosi
upon
present
patient
therefor
treatment
usual
must
initi
empir
basi
howev
ed
bedsid
test
cold
agglutinin
ca
potenti
interest
see
tabl
instruct
format
ca
nonspecif
earli
igm
reaction
red
cell
antigen
develop
patient
week
infect
accord
one
seri
patient
posit
mycoplasma
serolog
incid
ca
highest
pediatr
popul
patient
age
year
decreas
age
age
year
age
mild
form
hemagglutin
may
also
occur
condit
eg
viral
infect
vascul
lymphoma
lead
loss
specif
influenza
import
confound
caus
ca
seroposit
case
wherea
condit
usual
preclud
suspicion
pneumonia
infect
clinic
ground
alon
appropri
clinic
set
ie
lower
respiratori
tract
infect
suspect
eg
presenc
skin
rash
posit
ca
test
usual
suggest
help
diagnos
pneumonia
infect
also
illustr
seri
patient
lower
respiratori
infect
preval
pneumonia
sensit
specif
cold
agglutin
test
respect
use
cutoff
titer
bedsid
version
test
normal
turn
posit
titer
recent
hemagglutin
wide
use
routin
laboratori
test
pneumonia
infect
sinc
advent
highli
specif
serolog
see
use
ca
test
question
mani
author
howev
recent
data
demonstr
reason
test
valid
appropri
clinic
set
suggest
ca
test
may
underestim
specif
serolog
nowaday
import
routin
laboratori
test
result
normal
take
day
even
day
pair
serum
sampl
analyz
serolog
becom
posit
week
onset
symptom
igm
lead
serolog
respons
practic
alway
present
children
wherea
often
absent
young
adult
age
onward
due
experi
reinfectionth
major
adult
year
age
isol
igg
respons
seen
patient
iga
may
serv
substitut
earli
respons
marker
past
ig
assay
complement
fixat
cf
test
sensit
specif
respect
nowaday
superior
eia
techniqu
use
yield
sensit
specif
respect
igm
igg
measur
ig
test
consid
posit
either
titer
fourfold
increas
titer
pair
serum
sampl
taken
week
apart
case
patient
elev
igm
igg
level
persist
sever
month
year
respect
importantli
note
emerg
physician
commerci
rapid
bedsid
test
igm
igg
requir
min
recent
develop
repres
potenti
use
costli
per
test
altern
bedsid
agglutinin
immedi
result
unpair
sampl
sensit
roughli
similar
cold
agglutinin
test
direct
unamplifi
antigen
test
sputum
indirect
immun
assay
antigencaptur
eia
direct
nucleotid
detect
scarc
use
today
insensit
requir
high
antigen
densiti
sampl
unspecif
due
crossreact
mycoplasma
speci
respiratori
tract
pcr
nucleic
acid
amplif
method
provid
result
specif
within
day
yet
sensit
current
around
test
avail
routin
center
howev
method
may
becom
much
import
futur
valid
progress
mycoplasma
cultur
throat
swab
sputum
organ
tissu
sensit
around
requir
meticul
handl
specimen
elabor
microbiolog
test
take
week
grow
henc
mainli
use
clinic
studi
manag
extrapulmonari
complic
routin
treatment
acut
set
empir
accord
current
guidelin
firstlin
option
bacteri
agent
atyp
pneumonia
includ
pneumonia
consist
macrolid
tetracyclin
need
eg
case
suspect
advers
reaction
firstlin
antibiot
newer
quinolon
would
altern
eg
levofloxacin
moxifloxacin
although
pneumonia
infect
selflimit
antibiot
treatment
believ
allevi
sever
symptom
shorten
cours
diseas
compar
treatment
fact
treatment
lead
neg
pcr
mycoplasma
within
h
suggest
may
also
reduc
infect
spread
among
famili
member
inde
antibiot
prophylaxi
proven
effect
prevent
spread
infect
close
commun
among
militari
recruit
present
unknown
extrapulmonari
complic
sj
avoid
earli
antimycoplasm
treatment
summar
pneumonia
due
pneumonia
atyp
agent
alway
possibl
diagnosi
patient
present
ed
sign
upper
airway
infect
overlook
follow
sign
may
suggest
entiti
order
histori
exposur
keep
mind
famili
member
may
develop
symptom
interv
associ
skin
symptom
age
year
elderli
usual
unaffect
product
cough
fever
headach
musculoskelet
pain
addit
test
chest
radiograph
studi
bedsid
cold
agglutinin
obtain
subsequ
decis
whether
patient
hospit
two
pneumonia
sever
score
avail
